Treatment-Mediated Changes in Human Immunodeficiency Virus (HIV) Type 1 RNA and CD4 Cell Counts

Lindsey, Jane C.; Hughes, Michael D.; McKinney, Ross E.; Cowles, Mary K.; England, Janet A.; Baker, Carol J.; Burchett, Sandra K.; Kline, Mark W.; Kovacs, Andrea; Moye, Jack
November 2000
Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1385
Academic Journal
Evaluates the predictive value of antiretroviral treatment-mediated changes in 3 markers of human immunodeficiency virus type 1 disease progression. HIV-1 RNA level; CD4 cell count; CD4 percentage; Weight growth failure; Cognitive decline; Survival of HIV-infected children; Differential age effects on pediatric-specific clinical outcomes.


Related Articles

  • Randomized Study of Saquinavir with Ritonavir or Nelfinavir Together with Delavirdine, Adefovir... Gulick, Roy M.; Hu, X. Joan; Fiscus, Susan A.; Fletcher, Courtney V.; Haubrick, Richard; Cheng, Hailong; Acosta, Edward; Lagakos, Stephen W.; Swanstrom, Ronald; FischL, William; Pettinelli, Carla; Katzenstein, David // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1375 

    Compares antiretroviral activity among salvage therapy regimens for HIV infections. Administration of saquinavir with ritonavir or nelfinavir together with delavirdine and/or adefovir; Monitoring of antiretroviral response between baseline and week 16; Percentage of patients who experienced...

  • The Relationship between Virus Load Response to Highly Active Antiretroviral Therapy and Change... DeHovitz, Jack A.; Kovacs, Andrea; Feldman, Joseph G.; Anastos, Kathyrn; Young, Mary; Cohen, Mardge; Gange, Stephen J.; Melnick, Sandra; Greenblatt, Ruth M. // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1527 

    Assesses the relationship between the pattern of virus load response to highly active antiretroviral therapy (HAART) and change in CD4 cell counts among HIV-1 infected women. Difference in trend in CD4 cell count by response to HAART; Observation of higher CD4 cell counts in patients who...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Jul2001, Vol. 15 Issue 7, p399 

    Reports on various developments in antiviral research as of July 2001. Filing with the United States Food and Drug Administration by Gilead Sciences for its antiviral agent tenovir; Impact of the combination therapy of AZT and 3TC on the transmission rate of HIV between mother and infant;...

  • Selection of Drug-Resistant Variants in the Female Genital Tract of... Si-Mohamed, Ali; Kazatchkine, Michel D.; Heard, Isabelle; Goujon, Christophe; Prazuck, Thierry; Aymard, Guy; Cessot, Gilles; Yu-Hung Kuo; Bernard, Marie-Charlotte; Diquet, Bertrand; Malkin, Jean-Elie; Gutmann, Laurent; Belec, Laurent // Journal of Infectious Diseases;7/1/2000, Vol. 182 Issue 1, p112 

    Investigates the presence of free HIV-1 RNA, cell-associated proviral DNA and HIV-1 variants with drug-resistance mutations and the local concentration of antiviral drugs in the genital secretions of women receiving antiretroviral therapy. Demographic characteristics and biological findings;...

  • T-20 SHOWS PROMISE.  // AIDS Patient Care & STDs;Mar1999, Vol. 13 Issue 3, p200 

    Reports on the results of the first multidose human trial of the antiretroviral T-20. Decrease in patients' viral load; Results of similar trials using triple-drug HAART and four-drug HAART.

  • Transmission Fitness of Drug-Resistant Human Immunodeficiency Virus and the Prevalence of Resistance in the Antiretroviral-Treated Population. Brown, Andrew J. Leigh; Frost, Simon D.W.; Mathews, W. Christopher; Dawson, Keith; Hellmann, Nicholas S.; Daar, Eric S.; Richman, Douglas D.; Little, Susan J. // Journal of Infectious Diseases;2/15/2003, Vol. 187 Issue 4, p683 

    Although the prevalence of drug-resistant strains in primary human immunodeficiency virus (HIV) infection in North America has recently increased, their transmission fitness remains unknown. The present study estimated the frequency of transmission of drug-resistant HIV from patients receiving...

  • Pediatric HIV-AIDS: Challenges We Face Today. Shah, Ira; Madvariya, Monica // JK Science;Jul-Sep2013, Vol. 15 Issue 3, p109 

    The authors comments on the challenges experienced by doctors in addressing HIV-AIDS in children in Mumbai, India. The authors states that about 70,000 children below 15 years old have HIV in India while 21,000 of them get the infection by parent-to-children transmission (PPTCT). Moreover, they...

  • The Antiviral Activity, Mechanism of Action, Clinical Significance and Resistance of Abacavir in the Treatment of Pediatric AIDS. Melroy, Joel; Nair, Vasu // Current Pharmaceutical Design;Nov2005, Vol. 11 Issue 29, p3847 

    The novel carbocyclic nucleoside, abacavir, is metabolized in cells to carbovir triphosphate which is a potent inhibitor of HIV reverse transcriptase (Ki 0.021 μM with calf thymus DNA template primer). Abacavir exhibits potent in vitro antiviral activity against wild-type HIV-1 (IC50 4.0...

  • Abacavir.  // Reactions Weekly;4/15/2006, Issue 1097/1098, p6 

    Reports on the case of an HIV-infected 11-year-old boy, who had been receiving lamivudine and efavirenz long-term when abacavir was added to his antiretroviral regimen. Mood changes observed by the boy's parents one month after taking abacavir; Treatment given to the boy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics